1 Introduction Genetic testing for serious disease risk has evolved from a specialized clinic-based service to one that is widely available to consumers. This transformation has been influenced by the rise and rapid growth of direct-to-consumer genetic testing (DTC-GT) (Majumder et al. 2021). Since its emergence in the early 2000s, DTC-GT has changed significantly. Initially, consumers ordered tests and received results without the involvement of a healthcare provider (Hogarth et al.